| Literature DB >> 24965446 |
Matthew Jefferson1, Andras Donaszi-Ivanov1, Sean Pollen2, Tamas Dalmay2, Gerhard Saalbach3, Penny P Powell4.
Abstract
UNLABELLED: The viral N-terminal protease N(pro) of pestiviruses counteracts cellular antiviral defenses through inhibition of IRF3. Here we used mass spectrometry to identify a new role for N(pro) through its interaction with over 55 associated proteins, mainly ribosomal proteins and ribonucleoproteins, including RNA helicase A (DHX9), Y-box binding protein (YBX1), DDX3, DDX5, eIF3, IGF2BP1, multiple myeloma tumor protein 2, interleukin enhancer binding factor 3 (IEBP3), guanine nucleotide binding protein 3, and polyadenylate-binding protein 1 (PABP-1). These are components of the translation machinery, ribonucleoprotein particles (RNPs), and stress granules. Significantly, we found that stress granule formation was inhibited in MDBK cells infected with a noncytopathic bovine viral diarrhea virus (BVDV) strain, Kyle. However, ribonucleoproteins binding to N(pro) did not inhibit these proteins from aggregating into stress granules. N(pro) interacted with YBX1 though its TRASH domain, since the mutant C112R protein with an inactive TRASH domain no longer redistributed to stress granules. Interestingly, RNA helicase A and La autoantigen relocated from a nuclear location to form cytoplasmic granules with N(pro). To address a proviral role for N(pro) in RNP granules, we investigated whether N(pro) affected RNA interference (RNAi), since interacting proteins are involved in RISC function during RNA silencing. Using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) silencing with small interfering RNAs (siRNAs) followed by Northern blotting of GAPDH, expression of N(pro) had no effect on RNAi silencing activity, contrasting with other viral suppressors of interferon. We propose that N(pro) is involved with virus RNA translation in the cytoplasm for virus particle production, and when translation is inhibited following stress, it redistributes to the replication complex. IMPORTANCE: Although the pestivirus N-terminal protease, N(pro), has been shown to have an important role in degrading IRF3 to prevent apoptosis and interferon production during infection, the function of this unique viral protease in the pestivirus life cycle remains to be elucidated. We used proteomic mass spectrometry to identify novel interacting proteins and have shown that N(pro) is present in ribosomal and ribonucleoprotein particles (RNPs), indicating a translational role in virus particle production. The virus itself can prevent stress granule assembly from these complexes, but this inhibition is not due to N(pro). A proviral role to subvert RNA silencing through binding of these host RNP proteins was not identified for this viral suppressor of interferon.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24965446 PMCID: PMC4178888 DOI: 10.1128/JVI.00984-14
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103
Cellular proteins associated with GST-tagged Npro
| Peptide abundance rank | Accession no. | Protein identified | Mol mass | Association with Npro at GSH concn (mM) of: | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 | 30 | ||||||||||
| No pI·C | pI·C | No pI·C | pI·C | ||||||||
| % ID | No. of peptides | % ID | No. of peptides | % ID | No. of peptides | % ID | No. of peptides | ||||
| 1 | Glutathione | 23 | 100 | 7 | 100 | 10 | 100 | 9 | 100 | 9 | |
| 2 | 40S ribosomal protein S3a | 30 | 100 | 6 | 100 | 4 | 100 | 3 | 100 | 4 | |
| 3 | 40S ribosomal protein S2 | 31 | 100 | 3 | 100 | 1 | 100 | 3 | 100 | 3 | |
| 4 | Heterogeneous nuclear ribonucleoprotein U | 91 | 100 | 6 | 100 | 2 | 100 | 4 | 100 | 4 | |
| 5 | Y-box-binding protein 1 (YBX-1) | 36 | 100 | 4 | 100 | 4 | 100 | 5 | 100 | 4 | |
| 6 | 60S ribosomal protein L7a | 30 | 100 | 3 | 85 | 1 | 100 | 3 | 100 | 5 | |
| 7 | Nucleolin | 77 | 100 | 4 | 100 | 2 | 100 | 3 | 100 | 4 | |
| 8 | 60S ribosomal protein L23a | 18 | 100 | 4 | 100 | 4 | 100 | 2 | 100 | 3 | |
| 9 | 60S ribosomal protein L3 | 46 | 100 | 3 | 99 | 1 | 100 | 2 | 83 | 1 | |
| 10 | 40S ribosomal protein S14 | 16 | 100 | 2 | 100 | 1 | 100 | 2 | 100 | 2 | |
| 11 | La autoantigen, Sjoegren syndrome type B antigen (SS-B) | 47 | 100 | 3 | 100 | 2 | 100 | 3 | 100 | 3 | |
| 12 | 40S ribosomal protein S8 | 24 | 100 | 2 | 99 | 1 | 100 | 1 | 100 | 3 | |
| 13 | Ribosomal protein L12 | 21 | 100 | 2 | 100 | 2 | 100 | 2 | 100 | 2 | |
| 14 | 60S ribosomal protein L13 | 24 | 100 | 2 | 99 | 1 | 100 | 1 | 100 | 3 | |
| 15 | 40S ribosomal protein S15a | 15 | 100 | 2 | 100 | 2 | 100 | 2 | 99 | 1 | |
| 16 | 40S ribosomal protein S5 | 23 | 100 | 2 | 100 | 2 | 100 | 2 | 100 | 3 | |
| 17 | 40S ribosomal protein S13 | 17 | 100 | 3 | 100 | 2 | 100 | 2 | 99 | 1 | |
| 18 | Heterogeneous nuclear ribonucleoprotein M | 65 | 100 | 3 | 93 | 0 | 100 | 3 | 100 | 2 | |
| 19 | 40S ribosomal protein S7 | 22 | 100 | 1 | 46 | 0 | 100 | 1 | 99 | 1 | |
| 20 | 60S ribosomal protein L24 | 18 | 100 | 2 | 99 | 0 | 100 | 3 | |||
| 21 | ATP-dependent RNA helicase A (RHA, DEAH box protein 9) | 141 | 100 | 2 | 100 | 4 | 83 | 1 | |||
| 22 | 60S ribosomal protein L17 | 21 | 100 | 2 | 100 | 2 | 100 | 2 | 100 | 2 | |
| 23 | 60S ribosomal protein L26 | 17 | 100 | 1 | 98 | 1 | 99 | 0 | 100 | 1 | |
| 24 | Ribosomal protein P0 | 34 | 100 | 1 | 85 | 1 | 100 | 1 | 100 | 2 | |
| 25 | 60S ribosomal protein L7 | ? | 85 | 1 | 99 | 1 | 99 | 1 | 100 | 2 | |
| 26 | 60S ribosomal protein L31 | 14 | 100 | 2 | 100 | 2 | 100 | 2 | 100 | 2 | |
| 27 | 40S ribosomal protein S19 | 16 | 100 | 2 | 87 | 1 | 100 | 2 | |||
| 28 | Heterogeneous nuclear ribonucleoprotein G (hnRNP G) | 42 | 100 | 2 | 100 | 2 | 83 | 1 | |||
| 29 | Multiple myeloma tumor-associated protein 2 | 29 | 100 | 2 | 85 | 1 | 99 | 1 | 100 | 2 | |
| 30 | Interleukin enhancer-binding factor 3 (TCP80) | 95 | 100 | 2 | 100 | 2 | 100 | 2 | |||
| 31 | 60S ribosomal protein L19 | 23 | 100 | 2 | 100 | 1 | 60 | 0 | |||
| 32 | 60S ribosomal protein L36a | 12 | 98 | 1 | 84 | 0 | 100 | 1 | 83 | 1 | |
| 33 | 60S ribosomal protein L15 | 24 | 98 | 1 | 33 | 0 | 87 | 1 | 99 | 1 | |
| 34 | 60S ribosomal protein L4 | 48 | 85 | 1 | 99 | 1 | 100 | 1 | |||
| 35 | Heterogeneous nuclear ribonucleoprotein H (hnRNP H) | 49 | 100 | 3 | 85 | 1 | 36 | 0 | 48 | 0 | |
| 36 | Guanine nucleotide-binding protein-like 3 | 62 | 100 | 1 | 85 | 1 | 100 | 2 | |||
| 37 | Heterogeneous nuclear ribonucleoprotein K (hnRNP K) | 51 | 85 | 1 | 100 | 2 | 100 | 2 | |||
| 38 | Plasminogen activator inhibitor 1 RNA-binding protein | 45 | 85 | 1 | 85 | 1 | 100 | 2 | |||
| 39 | U2 small nuclear ribonucleoprotein B″ (SU2 snRNP B) | 25 | 99 | 1 | 100 | 2 | 70 | 0 | |||
| 40 | 28S ribosomal protein S23 (mitochondrial) | 22 | 100 | 1 | 85 | 1 | 48 | 0 | |||
| 41 | Polyadenylate-binding protein 1 (PABP-1) | 71 | 99 | 1 | 100 | 2 | |||||
| 42 | 60S ribosomal protein L10 | 25 | 100 | 2 | 83 | 1 | |||||
| 43 | H/ACA ribonucleoprotein complex subunit 4 | 58 | 60 | 0 | 99 | 1 | |||||
| 44 | Heterogeneous nuclear ribonucleoproteins A2/B1 | 37 | 56 | 0 | 99 | 1 | |||||
| 45 | Synaptotagmin binding, cytoplasmic RNA interacting protein variant | 60 | 100 | 1 | |||||||
Npro interacts with ribosomal and ribonucleoproteins, components of ribonuclear particles (RNPs). Interaction of Npro with cellular proteins was identified by mass spectrometry analysis. Recombinant GST-tagged Npro was used to pull down cellular binding partners from HEK293 cells. Cells were either control (“no. pI·C”) or transfected with poly(I·C) (pI·C) (dsRNA) for 4 h before lysis. Beads were eluted with low (10 mM) or high (30 mM) glutathione (GSH). Proteins binding to GST alone were used for a control. The accession number and molecular mass for each protein are shown in order of abundance of peptides found.
Molecular mass.
ID, identity.
Mass spectrometry identification of cellular proteins binding to Npro with or without zinc
| Peptide abundance rank | Accession no. | Protein identified | Mol mass | Binding to Npro with: | |||
|---|---|---|---|---|---|---|---|
| No Zn | Zn present | ||||||
| % binding | No. of peptides | % ID | No. of peptides | ||||
| 1 (21) | ATP-dependent RNA helicase A; DEAH box protein 9 | 141 | 100 | 30 | 100 | 50 | |
| 2 | Glutathione | 26 | 100 | 11 | 100 | 9 | |
| 3 | C7DJS2 | Glutathione | 17 | 100 | 2 | 100 | 2 |
| 4 | Heterogeneous nuclear ribonucleoprotein M | 78 | 100 | 6 | 100 | 6 | |
| 5 (2) | 40S ribosomal protein S3a | 30 | 100 | 1 | 100 | 7 | |
| 6 | 40S ribosomal protein S3 | 27 | 100 | 2 | 100 | 7 | |
| 7 | Tyrosine-tRNA ligase | 59 | 100 | 9 | |||
| 8 | B5BTY4 | ATP-dependent RNA helicase DDX3X | 73 | 100 | 2 | 100 | 6 |
| 9 | B1AHM1 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 | 73 | 99 | 1 | 100 | 5 |
| 10 | Insulin-like growth factor 2 mRNA-binding protein 1 | 63 | 100 | 2 | 100 | 5 | |
| 11 | Lupus Ku autoantigen protein p70 | 70 | 39 | 0 | 100 | 5 | |
| 12 (38) | Plasminogen activator inhibitor 1 RNA-binding protein | 45 | 62 | 0 | 100 | 2 | |
| 13 | 40S ribosomal protein S5 | 23 | 78 | 1 | 100 | 5 | |
| 14 | 40S ribosomal protein S4 | 30 | 78 | 1 | 100 | 3 | |
| 15 | Eukaryotic translation initiation factor 3 subunit L (eIF3l) | 67 | 35 | 0 | 100 | 3 | |
| 16 | ATP-dependent helicase RENT1 | 124 | 99 | 1 | 100 | 3 | |
| 17 (41) | Polyadenylate-binding protein 1 (PABP-1) | 71 | 25 | 0 | 100 | 3 | |
| 18 | Signal recognition particle 54-kDa protein; (SRP54) | 56 | 18 | 0 | 100 | 2 | |
| 19 | Signal recognition particle 72-kDa protein (SRP72) | 75 | 100 | 3 | |||
| 20 | Phenylalanine-tRNA ligase alpha subunit | 58 | 100 | 3 | |||
| 21 (45) | Synaptotagmin binding, cytoplasmic RNA interacting protein | 60 | 100 | 3 | |||
| 22 | Heterogeneous nuclear ribonucleoprotein A1 | 34 | 100 | 2 | 99 | 1 | |
| 23 | B3KNR3 | Glutathione | 19 | 99 | 1 | 99 | 1 |
| 24 (19) | 40S ribosomal protein S7 | 22 | 98 | 1 | 100 | 2 | |
| 25 (30) | Interleukin enhancer-binding factor 3; TCP80 | 95 | 78 | 1 | 100 | 3 | |
| 26 | Splicing factor 3B subunit 2 | 100 | 78 | 1 | 100 | 2 | |
| 27 | Signal recognition particle 68-kDa protein | 71 | 100 | 3 | |||
| 28 | Ribophorin II (RPN-II) | 69 | 100 | 2 | |||
| 29 | Signal recognition particle 9-kDa protein; SRP9 | 10 | 100 | 2 | |||
| 30 | RNA polymerase II-associated protein 3 | 76 | 100 | 3 | |||
| 31 (11) | La autoantigen; Sjoegren syndrome type B antigen (SS-B) | 47 | 100 | 3 | |||
| 32 | 60S ribosomal protein L18a | 21 | 100 | 3 | |||
| 33 | Signal recognition particle 14-kDa protein | 15 | 100 | 2 | |||
| 34 | Heterogeneous nuclear ribonucleoproteins C1/C2 | 34 | 78 | 1 | 100 | 2 | |
| 35 | 60S ribosomal protein L11 | 20 | 78 | 1 | 100 | 2 | |
| 36 | 40S ribosomal protein S23 | 16 | 41 | 0 | 100 | 2 | |
| 37 | 40S ribosomal protein S13 | 17 | 100 | 3 | |||
| 38 | Desmoglein 1 | 114 | 100 | 3 | |||
| 39 | Importin subunit alpha | 58 | 100 | 2 | |||
| 40 | Heterogeneous nuclear ribonucleoprotein U-like protein 1 | 96 | 100 | 2 | |||
| 41 | Desmoplakin 3 | 82 | 100 | 1 | |||
| 42 | 60S ribosomal protein L21 | 19 | 100 | 1 | |||
| 43 | Pentatricopeptide repeat-containing protein 3 (mitochondrial) | 79 | 100 | 1 | |||
| 44 | Valine-tRNA ligase | 140 | 99 | 1 | |||
| 45 | F8W7C6 | 60S ribosomal protein L10 | 19 | 100 | 2 | ||
| 46 | ATP-dependent RNA helicase DHX15 (DEAH box protein 15) | 91 | 100 | 2 | |||
| 47 | ATP-dependent RNA helicase DDX5; DEAD box protein 5 | 69 | 100 | 2 | |||
| 48 (44) | Heterogeneous nuclear ribonucleoproteins A2/B1 | 37 | 100 | 2 | |||
| 49 | Eukaryotic translation initiation factor 3 (eIF-3-beta) | 37 | 100 | 2 | |||
| 50 | Threonyl-tRNA synthetase variant | 83 | 100 | 2 | |||
| 51 | Heterogeneous nuclear ribonucleoprotein A/B | 36 | 100 | 1 | |||
| 52 | Acidic (leucine-rich) nuclear phosphoprotein 32 | 29 | 100 | 1 | |||
| 53 | 40S ribosomal protein S25 | 14 | 99 | 1 | |||
| 54 | YTH domain family protein 2; high-glucose-regulated protein 8 | 62 | 99 | 1 | |||
| 55 | 60S ribosomal protein L35a | 13 | 99 | 1 | |||
Npro binding to cellular proteins through TRASH domain by zinc chelation. Cellular proteins associated with Npro in the presence or absence or zinc, detected by Orbitrap mass spectrometry analysis.
The accession number and molecular mass for each protein are shown in order of abundance of peptides found. Proteins also identified in Table 1 are indicated by numbers in parentheses.
Molecular mass.
ID, identity.
FIG 1(A) MDBK cells infected with BVDV are protected from stress-induced apoptosis. (i) Control MDBK cells transfected with YBX1-V5 and treated with NaA for 4 h. (ii) Cells infected with BVDV for 48 h postinfection (hpi), transfected with YBX1-V5 overnight, and treated with NaA for 4 h. YBX-V5 was detected with anti-V5 MAb and anti-mouse Alexa 488 secondary antibody. Virus was detected with V182 hyperimmune serum and anti-bovine cy5 secondary antibody. (iii) MDBK cells transfected with TIA1-mCherry plasmid and treated with NaA for 4 h. (TIA was pseudocolored green for consistency). (iv) MDBK cells infected with BVDV for 48 hpi, transfected with TIA1-mCherry, and treated with NaA for 4 h. Virus was detected with V182 hyperimmune serum and anti-bovine cy5 secondary antibody, and TIA1 was pseudocolored green. (B) BVDV infection decreases stress-induced caspase 3/7 activation. MDBK cells, either uninfected (−) or infected with (+) BVDV noncytopathic (ncp) Kyle for 48 h, were stressed with NaA for 4 h. The graph shows the fold increase in caspase activity normalized to that of control cells and significance with one -sided t test value, P = 0.00004.
FIG 2Interaction and colocalization of Npro with Y-box protein 1 (YBX-1) requires the zinc-binding TRASH motif. (A) Npro localization in BVDV-infected MDBK cells. (i) Control MDBK cells transfected with Npro-GFP. (ii) MDBK cells transfected with Npro-GFP and treated with NaA for 4 h. (iii) Cells infected with BVDV for 48 hpi, transfected with Npro-GFP for 24 h, and treated with NaA for 4 h. Virus was detected with V182 bovine hyperimmune serum and anti-bovine cy5 secondary antibody. (B) Npro codistributes with YBX1 to large cytoplasmic stress granules. Cells stably expressing Npro-mCherry and transfected with YBX-1-V5 were either untreated or treated with NaA for 4 h. YBX1 was detected using anti-V5 MAb and anti-mouse Alexa 488 secondary antibody, and DNA was stained with 4′,6-diamidino-2-phenylindole (DAPI) (blue). (i) Control untreated HeLa cells, (ii) Cells stably expressing Npro-mCherry, transfected with YBX1-V5 and treated with NaA for 4 h. (iii) Cells stably expressing mutant Npro C112R-mCherry and transfected with YBX1-V5 and treated with NaA for 4 h. (C) Protein pulldown of HeLa cell lysates with recombinant Npro shows interaction with endogenous cellular YBX1 requiring zinc. The GST and GST-Npro recombinant proteins were washed in zinc buffer or zinc chelator, TPEN. Glutathione-Sepharose beads were used to pull down GST-Npro and its cobinding proteins. Top panel, endogenous YBX1 detected in cell lysates at 36 kDa with an anti-YBX1 antibody; middle panel, GST and GST-Npro recombinant proteins detected using anti-GST antibody and anti-Npro, respectively; bottom panel, HeLa cell lysates incubated with GST and GST-Npro proteins were pulled down with glutathione-Sepharose beads, washed extensively, and separated by SDS-PAGE. Proteins were transferred to membranes and probed with rabbit YBX1 antibody, which was detected with anti-rabbit-HRP by enhanced chemiluminescence (ECL). (D) Interaction of Npro with YBX1 increases after stress. Cells stably expressing Npro-mCherry were transfected with YBX1-V5, and cells were untreated (−) or treated (+) with sodium arsenate for 4 h (NaA). Lysates were pulled down with anti-V5 antibody bound to Sepharose beads. Top panels, Western blots of cell lysates either untreated (−) or treated (+) with NaA to detect YBX-V5 with anti-V5 monoclonal antibody (left) or Npro with rabbit anti-Npro antibody (right) using anti-mouse or anti-rabbit HRP antibodies, respectively. Bottom panels, immunoprecipitation of proteins using an anti-V5 antibody bound to Sepharose beads, followed by transfer of proteins to membranes and Western blotting with anti-V5 (left panel) or anti-Npro (right panel) antibodies. (E) Npro and YBX accumulate following stress. (i) Lysates from control cells (−) or cells expressing Npro-mCherry (+ Npro), either untreated (−NaA) or stressed for 4 h (+NaA), were blotted with antibodies against Npro and actin. (ii) Lysates from control cells (−) or cells expressing Npro (+Npro) either untreated (−) or treated with NaA (+) for 4 h were blotted with anti-YBX1 and antiactin antibodies.
FIG 3Pestivirus Npro forms a complex with ribonucleoproteins and redistributes to stress granules. (A) Npro redistribution with TIA1, DDX1, DDX3, and DCP1a following stress. Cells were either untreated (CON) or subjected to oxidative stress for 4 h (+NaA). Cell expressing Npro-GFP were cotransfected with TIA1-mCherry (i). Cells expressing Npro-mCherry were cotransfected with DDX1-V5 (ii), DDX3-Myc (iii), or DCP1a-V5 (iv), which were detected with anti-V5 or anti-Myc MAbs and secondary anti-mouse Alexa 488 antibodies. (B) Codistribution of YBX1 and TIA1-containing particles with RNA helicases DDX1 and DDX3. HeLa cells were transfected with plasmids encoding DDX1-V5 (i) or DDX3-Myc (ii) and treated with NaA for 4 h. Endogenous YBX1 was detected with rabbit anti-YBX1 and an anti-rabbit Alexa 594 secondary antibody, and DDX1 and DDX3 were detected with V5 and Myc MAbs, respectively, and an anti-mouse Alexa 488 secondary antibody. HeLa cells were cotransfected with a plasmid encoding TIA1-mCherry and YBX1-V5 (iii) or DCP1a-V5 (iv), detected using anti-V5 with anti-mouse Alexa 488 secondary antibody.
FIG 4RNA helicase A (DHX9) binds to Npro and redistributes from the nucleus to cytoplasmic stress granules following stress. (A) RHA tagged with HA was transfected into HEK293 cells, and lysates were incubated with GST or GST-Npro recombinant proteins. Cobinding proteins were pulled down with glutathione-Sepharose beads. Top panel, Western blot of recombinant protein with anti-GST antibody (RP); middle panel, Western blot of cell lysates expressing RHA with anti-HA antibody detected with anti-mouse HRP secondary antibody; bottom panel, Western blot of proteins pulled down with glutathione-Sepharose beads and detected with anti-HA antibody. (B) GST-Npro expressed alone (−) or with RHA-HA (+) in HEK293 cells was pulled down using glutathione-Sepharose beads from cells lysates. Top panel, Western blot of cell lysates with anti-Npro antibody; middle panel, Western blot of cell lysates with anti-HA antibody; bottom panel, Western blot of proteins pulled down with glutathione beads using anti-Npro antibody. (C) RNA helicase A (DHX9) redistributes from the nucleus to cytoplasmic stress granules with Npro following stress. (i) HeLa cells were cotransfected with Npro-mCherry and either RHA-GFP (RHA +Npro) or mutant RHA R1163A-GFP (R1163A +Npro). Cells were either untreated (CON) or subjected to oxidative stress (+NaA). (ii) MBDK cells were infected with BVDV for 48 h and transfected with either RHA-GFP or mutant RHA R1163A GFP for 24 h. Cells were either untreated (CON) or subjected to oxidative stress (+NaA). (iii) HeLa cells were cotransfected with Npro-mCherry and La autoantigen-GFP. Cells were either untreated (CON) or subjected to oxidative stress (+NaA).
FIG 5Npro does not suppress RNA silencing.(i) Western blot of control HeLa cells (−), cells stably expressing Npro-mCherry (+Npro) (left panel), or HeLa cells silenced for RHA expression (RHA siRNA) (right panel). Npro was detected with a rabbit anti-Npro antibody and visualized with IRDye-labeled secondary antibodies. RHA was detected with mouse anti-RHA and visualized with HRP-labeled secondary antibody. (ii) Northern blot analysis of GAPDH mRNA levels following GAPDH silencing using a 32P-labeled GAPDH-specific primer. 1, control cells; 2, mock-treated cells; 3, nontargeting siRNA-treated cells; 4, GAPDH siRNA-treated cells. Control cells (left panel), cells expressing Npro (middle panel), and cells silenced for RHA (right panel) are shown. An 18S RNA blot is shown for equal loading.